Inovio Biomedical Company Profile

16:43 EDT 23rd March 2018 | BioPortfolio

Inovio Biomedical Corporation (AMEX: INO) is a leader in cancer and other medical therapies using electroporation-enabled delivery of useful biopharmaceuticals
Inovio Biomedical Corporation (AMEX: INO) is a late stage biomedical company developing novel therapies enabled by electroporation, with a focus on addressing critical unmet treatment needs in oncology. Clinical results validate its local cancer therapy's ability to preserve healthy tissue while selectively killing cancer cells in solid tumors. Compared to surgery, this treatment is simpler, superior in its ability to preserve tissue structure and function (providing quality of life benefits), and lower cost. Inovio's non-viral delivery platform enabled the first-ever clinical study to deliver a gene in humans using electroporation. With the validation of promising pre-clinical data and licensing agreements with Merck and Vical, the company's technology may be instrumental in achieving the potential of important therapeutic genes and DNA vaccines.


11494 Sorrento Valley Rd.
San Diego
United States of America


Phone: 858-597-6006 or 877-446-6846 (877-4-INOVIO)
Fax: 858-597-0451

News Articles [293 Associated News Articles listed on BioPortfolio]

Inovio amends agreement with ApolloBio

Shares of USA-based Inovio Pharmaceuticals were up 4.12% at $4.30 in premarket trading today, after it…

Inovio Pharmaceuticals Begins Phase 3 Trial With FDA Green Light

Recently, Inovio Pharmaceuticals (NASDAQ:INO) announced that it had received notice from the FDA that it could begin testing on its phase 3 clinical trial product. The product in question VGX-3100 is ...

Inovio inks amended pact with ApolloBio to develop & commercialize VGX─3100 in Greater China

Inovio Pharmaceuticals has entered an amended agreement providing ApolloBio Corporation with the exclusive right to develop and commercialize VGX─3100, Inovio's DNA immunotherapy product designed

Inovio, ApolloBio Close VGX-3100 Collaboration

Inovio receives $23 million upfront and additional $20 million in future milestones and royalties

Inovio Pharma begins phase 1b/2 immuno─oncology trial to evaluate atezolizumab in combo with INO─5401

Inovio Pharmaceuticals has announced initiation of a phase 1b/2 immuno─oncology trial to evaluate Genentech/Roche's atezolizumab (Tecentriq) in combination with Inovio's INO─5401, a T cell activat...

ApolloBio to develop Inovio’s VGX-3100 in Greater China

ApolloBio has signed an amended agreement to obtain exclusive development and commercialisation rights for Inovio Pharmaceuticals’ VGX-3100 in Greater China,...Read More... The post ApolloBio to dev...

Inovio reworks immunotherapy deal with eye to China

Under an amended agreement, ApolloBio will pay $23 million upfront for exclusive rights within Greater China for Inovio's HPV immunotherapy. 

ApolloBio and Inovio Alter $43 Million China Deal for HPV Immunotherapy

ApolloBio, a Beijing company focused on cancer, has amended its year-old deal to acquire China rights to Inovio's DNA immunotherapy aimed at pre-cancers caused by human papillomavirus (HPV). Under the...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Serostim [EMD Serono, Inc.]

Serostim [somatropin (rDNA origin) for injection]

PubMed Articles [363 Associated PubMed Articles listed on BioPortfolio]

DataMed - an open source discovery index for finding biomedical datasets.

Finding relevant datasets is important for promoting data reuse in the biomedical domain, but it is challenging given the volume and complexity of biomedical data. Here we describe the development of ...

Mini Review: Nanosheet Technology towards Biomedical Application.

The fabrication technique of ultrathin film (commonly known as nanosheets) has been significantly developed over the years. Due to the mechanical properties of nanosheets, such as high levels of adhes...

Assessing the Practice of Biomedical Ontology Evaluation: Gaps and Opportunities.

With the proliferation of heterogeneous health care data in the last three decades, biomedical ontologies and controlled biomedical terminologies play a more and more important role in knowledge repre...

Informatics for Precision Medicine and Healthcare.

The past decade has witnessed great advances in biomedical informatics. Biomedical informatics is an emerging field of healthcare that aims to translate the laboratory observation into clinical practi...

GRAM-CNN: a deep learning approach with local context for named entity recognition in biomedical text.

Best performing named entity recognition (NER) methods for biomedical literature are based on hand-crafted features or task-specific rules, which are costly to produce and difficult to generalize to o...

Clinical Trials [96 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain

BACKGROUND Shoulder pain is the third most common musculoskeletal disorder observed in primary care consultations after low back and neck pain. In the absence of successful outcome followi...

Companies [593 Associated Companies listed on BioPortfolio]

Inovio Biomedical Corporation

Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. T...

Inovio Biomedical

Inovio Biomedical Corporation (AMEX: INO) is a leader in cancer and other medical therapies using electroporation-enabled delivery of useful biopharmaceuticalsInovio Biomedical Corporation (AMEX: INO)...

Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. The company’s SynCon™ vaccines are designed...

Quertle, LLC

Quertle is a biomedical search engine focused on delivering informative results to biomedical researchers using advanced linguistic technologies, along with an in-depth und...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

More Information about "Inovio Biomedical" on BioPortfolio

We have published hundreds of Inovio Biomedical news stories on BioPortfolio along with dozens of Inovio Biomedical Clinical Trials and PubMed Articles about Inovio Biomedical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inovio Biomedical Companies in our database. You can also find out about relevant Inovio Biomedical Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record